Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of NovoBiotic Pharmaceuticals patents

List of NovoBiotic Pharmaceuticals patents

List of IntelliVision (company) patents

List of Catalina Marketing patents

List of Celeno patents

List of SBIR/STTR awards granted to Extend Biosciences

Companies in the Parametric insurance industry

Patents where

Current Assignee

Name

is

NovoBiotic Pharmaceuticals

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9402878 Depsipeptide and uses thereof	Patent 9402878 was granted and assigned to NovoBiotic Pharmaceuticals on August, 2016 by the United States Patent and Trademark Office.	NovoBiotic Pharmaceuticals	NovoBiotic Pharmaceuticals		United States Patent and Trademark Office	9402878	August 2, 2016
	‌ US Patent 10414800 Methods for producing a depsipeptide	Patent 10414800 was granted and assigned to NovoBiotic Pharmaceuticals on September, 2019 by the United States Patent and Trademark Office.	NovoBiotic Pharmaceuticals	NovoBiotic Pharmaceuticals		United States Patent and Trademark Office	10414800	September 17, 2019
	‌ US Patent 11174290 Depsipeptide and uses thereof	Patent 11174290 was granted and assigned to NovoBiotic Pharmaceuticals on November, 2021 by the United States Patent and Trademark Office.	NovoBiotic Pharmaceuticals	NovoBiotic Pharmaceuticals		United States Patent and Trademark Office	11174290	November 16, 2021
	‌ US Patent 11203616 Depsipeptides and uses thereof	Patent 11203616 was granted and assigned to NovoBiotic Pharmaceuticals on December, 2021 by the United States Patent and Trademark Office.	NovoBiotic Pharmaceuticals	NovoBiotic Pharmaceuticals		United States Patent and Trademark Office	11203616	December 21, 2021
	‌ US Patent 8097709 Macrolactam compounds	Patent 8097709 was granted and assigned to NovoBiotic Pharmaceuticals on January, 2012 by the United States Patent and Trademark Office.		NovoBiotic Pharmaceuticals		United States Patent and Trademark Office	8097709	January 17, 2012
	‌ US Patent 11891415 Depsipeptides and uses thereof	Patent 11891415 was granted and assigned to NovoBiotic Pharmaceuticals on February, 2024 by the United States Patent and Trademark Office.	NovoBiotic Pharmaceuticals	NovoBiotic Pharmaceuticals		United States Patent and Trademark Office	11891415	February 6, 2024
	‌ US Patent 11851458 Depsipeptide and uses thereof	Patent 11851458 was granted and assigned to NovoBiotic Pharmaceuticals on December, 2023 by the United States Patent and Trademark Office.	NovoBiotic Pharmaceuticals	NovoBiotic Pharmaceuticals		United States Patent and Trademark Office	11851458	December 26, 2023

7 results

0 selected

7 results

0 selected